Pharsight

BAXALTA PATENTS FACING OPPOSITIONS

Top patents of BAXALTA facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP1974014B1 19 Apr, 2017 Oligopeptide-Free Cell Culture Media NA 6
EP3064508B2 15 Mar, 2023 Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture NA 1
EP3277718B1 24 Mar, 2021 Dosage Regimen For Anti-Mif Antibodies Mar, 2036 1
EP2739641B2 15 Apr, 2020 Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes NA 1
EP3116534B1 29 May, 2019 Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders Mar, 2035 1
EP2652491B1 29 Nov, 2017 Eluate Collection Using Conductivity Gradient NA 1
EP2295547B1 20 Sep, 2017 Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression NA 1